CDT Equity CDT
NASDAQ CDT
$0.35 -0.25 (-42.28%)
As of: Sep 10, 2026 · 3:05 PM EDT

CDT Equity (CDT) Share-based Compensation (2023 - 2026)

CDT Equity's (CDT) quarterly Share-based Compensation came in at $1.3 million in Q2 2026, down 18.75% on a YoY basis from $1.6 million in Q2 2025, and down 7.14% quarter-over-quarter from $1.4 million in Q1 2026.

Analysis

CDT Equity (CDT) Share-based Compensation (2023 - 2026) Analysis & Trends

CDT Equity (CDT) has reported Share-based Compensation for 4 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Share-based Compensation fell 18.75% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2026 stood at $1.3 million (down 18.75% YoY), and the FY2025 full-year result was $2.8 million, up 16.67% from the prior year.
  • Share-based Compensation eased to $1.3 million in Q2 2026 per CDT's latest filing, from $1.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $72.4 million in Q3 2023 and bottomed at -$769000.0 in Q4 2025.
  • Historically, Share-based Compensation has averaged $6.5 million across 4 years, with a median of $1.3 million in 2026.
  • The sharpest annual moves came in 2025 and 2026: Share-based Compensation sank 783.91% in 2025, then surged 498.29% in 2026.
  • Over 4 years, Share-based Compensation stood at $393000.0 in 2023, then plunged by 122.14% to -$87000.0 in 2024, then tumbled by 783.91% to -$769000.0 in 2025, then surged by 269.05% to $1.3 million in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $1.3 million, $1.4 million, and -$769000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Johnson & Johnson 641.92 Bn 621.16 Bn 17.26 Bn -950.00 Mn
2 AbbVie 448.34 Bn 441.78 Bn 12.70 Bn 166.00 Mn
3 Merck 357.85 Bn 350.70 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 267.35 Bn 259.66 Bn 11.24 Bn -
5 Pfizer 156.52 Bn 144.82 Bn 10.94 Bn 249.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn -
7 Revolution Medicines 42.91 Bn 42.91 Bn - 277.20 Mn
8 Incyte 24.69 Bn 20.16 Bn 1.57 Bn 67.26 Mn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn 19.00 Mn
10 CDT Equity 183,138.46 183,138.46 - 1.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Mn
Mar 31, 2026 1.40 Mn
Dec 31, 2025 -769,000.00
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.60 Mn
Mar 31, 2025 234,000.00
Dec 31, 2024 -87,000.00
Sep 30, 2024 2.70 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 431,000.00
Dec 31, 2023 393,000.00
Sep 30, 2023 72.42 Mn
Mar 31, 2023 400,000.00